{"id":27513,"date":"2025-01-14T10:28:00","date_gmt":"2025-01-14T17:28:00","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/uncategorized\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a-2\/"},"modified":"2025-06-17T09:40:35","modified_gmt":"2025-06-17T16:40:35","slug":"afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/","title":{"rendered":"Afstyla: La primera terapia con factor VIII de cadena \u00fanica para pacientes con hemofilia A"},"content":{"rendered":"<p><a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/hemophilia-a-vs-b-whats-the-difference\/\">Hemofilia A<\/a> Los pacientes tienden a sangrar durante m\u00e1s tiempo que los individuos sanos debido a que su cuerpo carece de un factor de coagulaci\u00f3n sangu\u00ednea llamado factor VIII (FVIII).<\/p>\n\n\n\n<p>Si usted o su ser querido ha estado experimentando sangrados espont\u00e1neos y frecuentes sin ninguna causa evidente, es posible que desee considerar el uso de Afstyla despu\u00e9s de consultar con su m\u00e9dico.<\/p>\n\n\n\n<div  id=\"call-to-action-5e22c63cbc5248f6ebe34902fc4d068f\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia financiera\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Afstyla es <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8844480\/\" target=\"_blank\" rel=\"noreferrer noopener\">m\u00e1s eficaz para prevenir y tratar episodios de sangrado<\/a> en pacientes con hemofilia A grave que otros productos de factor VIII de coagulaci\u00f3n sangu\u00ednea disponibles. Afstyla es la primera y \u00fanica terapia de factor VIII de cadena \u00fanica aprobada por la FDA que brinda protecci\u00f3n duradera contra hemorragias.<\/p>\n\n\n\n<p>En esta gu\u00eda, analizaremos el Afstyla y c\u00f3mo puede ayudar a los pacientes con hemofilia A. Tambi\u00e9n analizaremos su dosis est\u00e1ndar y proceso de administraci\u00f3n, posibles efectos secundarios, costos estimados y mucho m\u00e1s.<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_83 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Alternar tabla de contenido\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Palanca<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#What_Is_Afstyla_and_What_Is_It_Used_For\" >\u00bfQu\u00e9 es Afstyla y para qu\u00e9 se utiliza?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#How_Does_Afstyla_Work_and_Help_Patients_With_Hemophilia_A\" >\u00bfC\u00f3mo funciona Afstyla y ayuda a los pacientes con hemofilia A?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#What_Is_the_Standard_Dose_of_Afstyla_for_Hemophilia_A_Patients\" >\u00bfCu\u00e1l es la dosis est\u00e1ndar de Afstyla para pacientes con hemofilia A?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#1_Dosage_for_Routine_Prophylaxis\" >1. Dosis para profilaxis de rutina<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#2_Dosage_for_On-Demand_Treatment_and_Control_of_Bleeding_Episodes\" >2. Posolog\u00eda para el tratamiento a demanda y control de episodios hemorr\u00e1gicos<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#3_Dosage_for_Perioperative_Management_of_Bleeding\" >3. Dosis para el manejo perioperatorio del sangrado<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#How_Is_Afstyla_Administered\" >\u00bfC\u00f3mo se administra Afstyla?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#Administration_Process\" >Proceso de administraci\u00f3n<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#Side_Effects\" >Efectos secundarios<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#What_Precautions_Should_You_Take_Before_Using_Afstyla\" >\u00bfQu\u00e9 precauciones debe tomar antes de utilizar Afstyla?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#Afstyla_Cost\" >Costo del Afstyla<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#Manage_Hemophilia_A_with_AmeriPharma%C2%AE_Specialty_Pharmacy\" >Controle la hemofilia A con la farmacia especializada AmeriPharma\u00ae<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\" id=\"h-what-is-afstyla-and-what-is-it-used-for\"><span class=\"ez-toc-section\" id=\"What_Is_Afstyla_and_What_Is_It_Used_For\"><\/span>\u00bfQu\u00e9 es Afstyla y para qu\u00e9 se utiliza?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Afstyla, tambi\u00e9n conocido por su nombre gen\u00e9rico, <strong>factor antihemof\u00edlico (recombinante), de cadena sencilla<\/strong>, es un producto recombinante que contiene una forma de prote\u00edna del factor VIII elaborada en laboratorio.<\/p>\n\n\n\n<p>Esta forma artificial del factor VIII reemplaza temporalmente el factor de coagulaci\u00f3n VIII faltante y ayuda a coagular la sangre y detener el sangrado en pacientes con hemofilia A (un <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/understanding-hemophilia-gene-therapy-a-potential-game-changer-for-bleeding-disorders\/\">trastorno hemorr\u00e1gico<\/a> que se produce debido a una deficiencia de la prote\u00edna del factor de coagulaci\u00f3n VIII). La hemofilia A tambi\u00e9n se conoce como deficiencia cong\u00e9nita del factor VIII.<\/p>\n\n\n\n<p>El medicamento generalmente se prescribe a adultos y ni\u00f1os con hemofilia A y se utiliza en las siguientes circunstancias:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Para prevenir o reducir la frecuencia de episodios de sangrado (utilizado como agente profil\u00e1ctico)<\/li>\n\n\n\n<li>Para controlar hemorragias activas que ocurren debido a lesiones o traumatismos accidentales (se utiliza como tratamiento a demanda)<\/li>\n\n\n\n<li>Para prevenir y controlar los sangrados espont\u00e1neos que ocurren durante la cirug\u00eda (manejo perioperatorio).<\/li>\n<\/ul>\n\n\n\n<p>Cabe se\u00f1alar que el Afstyla recombinante no est\u00e1 aprobado para su uso en el tratamiento <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/von-willebrand-disease-vs-hemophilia-comparing-the-causes-symptoms-diagnosis-and-treatments\/\">enfermedad de von Willebrand<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-does-afstyla-work-and-help-patients-with-hemophilia-a\"><span class=\"ez-toc-section\" id=\"How_Does_Afstyla_Work_and_Help_Patients_With_Hemophilia_A\"><\/span>\u00bfC\u00f3mo funciona Afstyla y ayuda a los pacientes con hemofilia A?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Afstyla contiene un componente activo, lonoctocog alfa, que es una versi\u00f3n corta del factor VIII de coagulaci\u00f3n humano natural.<\/p>\n\n\n\n<p>El componente activo de Afstyla funciona como el factor VIII humano y se activa en el torrente sangu\u00edneo durante episodios de sangrado. Una vez activado, ayuda a formar un co\u00e1gulo al trabajar con otras prote\u00ednas sangu\u00edneas para detener el sangrado.<\/p>\n\n\n\n<p>Adem\u00e1s, la estructura monocatenaria del f\u00e1rmaco es una caracter\u00edstica \u00fanica que le permite unirse con mayor fuerza al factor de von Willebrand (VWF). Esta prote\u00edna estabiliza el factor VIII en la sangre durante un per\u00edodo prolongado.<\/p>\n\n\n\n<p>Por lo tanto, al unirse al VWF, el Afstyla no se descompone r\u00e1pidamente, permanece activo durante m\u00e1s tiempo y funciona de manera m\u00e1s efectiva que los medicamentos tradicionales del factor VIII de coagulaci\u00f3n sangu\u00ednea.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-is-the-standard-dose-of-afstyla-for-hemophilia-a-patients\"><span class=\"ez-toc-section\" id=\"What_Is_the_Standard_Dose_of_Afstyla_for_Hemophilia_A_Patients\"><\/span>\u00bfCu\u00e1l es la dosis est\u00e1ndar de Afstyla para pacientes con hemofilia A?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La dosis est\u00e1ndar y la frecuencia de Afstyla se determinan en funci\u00f3n de la gravedad de la deficiencia del factor VIII, la extensi\u00f3n, la ubicaci\u00f3n, el tipo de sangrado, la condici\u00f3n cl\u00ednica del paciente y el peso corporal (kg).<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-1-dosage-for-routine-prophylaxis\"><span class=\"ez-toc-section\" id=\"1_Dosage_for_Routine_Prophylaxis\"><\/span>1. Dosis para profilaxis de rutina<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>El rango de dosificaci\u00f3n recomendado de este <a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/a-guide-to-hemophilia-medications-types-benefits-and-side-effects\/\">medicamentos para la hemofilia<\/a> para adultos y ni\u00f1os (\u226512 a\u00f1os de edad) es de 20 a 50 UI por kg de Afstyla, que debe administrarse de 2 a 3 veces por semana.<\/p>\n\n\n\n<p>Para los ni\u00f1os menores de 12 a\u00f1os, se administra una dosis de 30 a 50 UI por kg de 2 a 3 veces por semana.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-2-dosage-for-on-demand-treatment-and-control-of-bleeding-episodes\"><span class=\"ez-toc-section\" id=\"2_Dosage_for_On-Demand_Treatment_and_Control_of_Bleeding_Episodes\"><\/span>2. Posolog\u00eda para el tratamiento a demanda y control de episodios hemorr\u00e1gicos<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Para el tratamiento a demanda, se administra Afstyla para mantener los niveles de actividad del factor VIII dentro del rango objetivo:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>En caso de sangrado menor (por ejemplo, sangrado en articulaciones, sangrado muscular menor o sangrado oral), se administra Afstyla cada 12 a 24 horas para alcanzar niveles de FVIII de 20 a 40 UI\/dL hasta que se detenga el sangrado.<\/li>\n\n\n\n<li>En casos de sangrado moderado (por ejemplo, hemorragias musculares y articulares o traumatismos leves), el medicamento se administra cada 12 a 24 horas para mantener los niveles de actividad del FVIII entre 30 y 60 UI\/dL hasta que se resuelva el problema.<\/li>\n\n\n\n<li>En caso de sangrado grave o potencialmente mortal (por ejemplo, hemorragias musculares y cerebrales profundas, fracturas o traumatismo craneoencef\u00e1lico), la terapia se administra cada 8 a 24 horas para alcanzar niveles de FVIII de 60 a 100 UI\/dL hasta que el sangrado se detenga.<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-771b7cc507c4b3ed05ffa18195e07b1e\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tObtenga asistencia con el copago ahora\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#form\">Programar una consulta<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-3-dosage-for-perioperative-management-of-bleeding\"><span class=\"ez-toc-section\" id=\"3_Dosage_for_Perioperative_Management_of_Bleeding\"><\/span>3. Dosis para el manejo perioperatorio del sangrado<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Durante procedimientos quir\u00fargicos menores y mayores, se utiliza Afstyla para mantener los niveles de actividad del FVIII en el rango objetivo o por encima de \u00e9l, que son los siguientes:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Durante procedimientos quir\u00fargicos menores (por ejemplo, extracci\u00f3n dental), para mantener los niveles de actividad del FVIII entre 30 y 60 UI\/dL, el medicamento se administra cada 24 horas durante al menos un d\u00eda hasta que se complete la curaci\u00f3n.<\/li>\n\n\n\n<li>Durante procedimientos quir\u00fargicos mayores (p. ej., cirug\u00eda de reemplazo de cadera o neurocirug\u00eda), para mantener los niveles de actividad del FVIII entre 80 y 100 UI\/dl, el f\u00e1rmaco se administra cada 8 a 24 horas hasta la recuperaci\u00f3n completa. El tratamiento debe administrarse durante al menos otros 7 d\u00edas para mantener los niveles de actividad del FVIII entre 30 y 60 UI\/dl.<\/li>\n<\/ul>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"280\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii.jpg\" alt=\"A doctor pointing to a blood sample tube with his pen\" class=\"wp-image-27549\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii-300x200.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii-330x220.jpg 330w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii-86x57.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii-167x111.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii-280x187.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/01\/doctor-afstyla-factor-viii-370x247.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<h2 class=\"wp-block-heading\" id=\"h-how-is-afstyla-administered\"><span class=\"ez-toc-section\" id=\"How_Is_Afstyla_Administered\"><\/span>\u00bfC\u00f3mo se administra Afstyla?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El Afstyla se administra por v\u00eda intravenosa (inyectado en la vena). Este medicamento se presenta en viales monodosis como un polvo seco blanco o ligeramente amarillento que debe reconstituirse (diluirse) en agua est\u00e9ril o el diluyente incluido en el kit.<\/p>\n\n\n\n<p>Las siguientes son las dosis codificadas por colores disponibles de la terapia de factor VIII Afstyla:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Naranja: 250 UI por vial<\/li>\n\n\n\n<li>Azul: 500 UI por vial<\/li>\n\n\n\n<li>Verde: 1.000 UI por vial<\/li>\n\n\n\n<li>Turquesa: 1.500 UI por vial<\/li>\n\n\n\n<li>P\u00farpura: 2.000 UI por vial<\/li>\n\n\n\n<li>Cool Grey: 2500 UI por vial<\/li>\n\n\n\n<li>Amarillo: 3.000 UI por vial<\/li>\n<\/ul>\n\n\n\n<p>Se recomienda verificar siempre la potencia de la dosis prescrita impresa en la etiqueta antes de usarla.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-administration-process\"><span class=\"ez-toc-section\" id=\"Administration_Process\"><\/span>Proceso de administraci\u00f3n<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Tras recibir las instrucciones adecuadas de un profesional sanitario cualificado, el Afstyla puede ser administrado por un cuidador o por el paciente. A continuaci\u00f3n, se ofrecen algunos consejos \u00fatiles para administrar este medicamento de forma segura.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Aseg\u00farese de seguir una <a href=\"https:\/\/my.clevelandclinic.org\/health\/treatments\/aseptic-technique\" target=\"_blank\" rel=\"noreferrer noopener\">t\u00e9cnica as\u00e9ptica<\/a> al inyectar el medicamento para evitar el riesgo de infecciones relacionadas con el lugar de la inyecci\u00f3n.<\/li>\n\n\n\n<li>No combine Afstyla con otros medicamentos.<\/li>\n\n\n\n<li>Utilice siempre inyecci\u00f3n intravenosa para administrar el medicamento.<\/li>\n\n\n\n<li>El medicamento debe administrarse dentro de las 4 horas siguientes a su reconstituci\u00f3n a temperatura ambiente.<\/li>\n\n\n\n<li>Solo debe administrarse una vez. Tras la administraci\u00f3n, deseche adecuadamente todos los suministros y la soluci\u00f3n sobrante.<\/li>\n<\/ul>\n\n\n\n<div  id=\"call-to-action-4c7fa2a4255c49ff68dabfa11c991d20\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tHabla con un especialista\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAcerca de la asistencia para copagos\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-side-effects\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span>Efectos secundarios<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Afstyla tiene menos efectos secundarios en comparaci\u00f3n con otros medicamentos de factor VIII disponibles.<\/p>\n\n\n\n<p>El perfil de seguridad del f\u00e1rmaco se evalu\u00f3 en uno de los programas de ensayos cl\u00ednicos de FVIII m\u00e1s grandes, con 258 participantes con hemofilia A. Aproximadamente 14 de los 258 participantes informaron los siguientes efectos secundarios durante los ensayos cl\u00ednicos:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Reacciones al\u00e9rgicas (hipersensibilidad) (observadas en hasta 1 de cada 10 personas)<\/li>\n\n\n\n<li>Mareos (observados en el 0,81% de las personas)<\/li>\n<\/ul>\n\n\n\n<p>Estos efectos secundarios son temporales y desaparecen despu\u00e9s de tomar los medicamentos recetados por un proveedor de atenci\u00f3n m\u00e9dica.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-what-precautions-should-you-take-before-using-afstyla\"><span class=\"ez-toc-section\" id=\"What_Precautions_Should_You_Take_Before_Using_Afstyla\"><\/span>\u00bfQu\u00e9 precauciones debe tomar antes de utilizar Afstyla?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Siempre consulte a su proveedor de atenci\u00f3n m\u00e9dica antes de usar Afstyla si:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>\u00bfEst\u00e1 embarazada o planea quedar embarazada?<\/li>\n\n\n\n<li>\u00bfEst\u00e1 amamantando?<\/li>\n\n\n\n<li>Te han dicho que tienes <a href=\"https:\/\/www.sciencedirect.com\/topics\/medicine-and-dentistry\/blood-clotting-factor-8-inhibitor#:~:text=Acquired%20FVIII%20inhibitors%20are%20autoantibodies,leads%20to%20functional%20FVIII%20deficiency.\" target=\"_blank\" rel=\"noreferrer noopener\">Inhibidores del FVIII<\/a> (porque este medicamento puede no funcionar si tiene inhibidores del factor VIII)<\/li>\n\n\n\n<li>Son al\u00e9rgicos a las prote\u00ednas de h\u00e1mster (porque Afstyla se fabrica utilizando esta prote\u00edna)<\/li>\n\n\n\n<li>\u00bfEst\u00e1 utilizando alg\u00fan medicamento de venta libre, suplementos o productos herbales?<\/li>\n\n\n\n<li>Tiene o ha tenido alg\u00fan problema m\u00e9dico.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-afstyla-cost\"><span class=\"ez-toc-section\" id=\"Afstyla_Cost\"><\/span>Costo del Afstyla<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>El costo del polvo intravenoso recombinante Afstyla para inyecci\u00f3n es de alrededor de $12 para un suministro de 1 polvo, dependiendo de la farmacia que visite.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-manage-hemophilia-a-with-ameripharma-specialty-pharmacy\"><span class=\"ez-toc-section\" id=\"Manage_Hemophilia_A_with_AmeriPharma%C2%AE_Specialty_Pharmacy\"><\/span>Controle la hemofilia A con la farmacia especializada AmeriPharma\u00ae<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>La terapia con factor VIII Afstyla ofrece beneficios terap\u00e9uticos duraderos para controlar y prevenir el sangrado frecuente, en comparaci\u00f3n con otros medicamentos con factor VIII. Sin embargo, es importante consultar con su m\u00e9dico antes de usar este medicamento.<\/p>\n\n\n\n<p>Si su m\u00e9dico considera que este medicamento es adecuado, puede contar con <a href=\"https:\/\/ameripharmaspecialty.com\/es\/about-us\/\">Farmacia especializada AmeriPharma\u00ae<\/a> para un apoyo integral.<\/p>\n\n\n\n<p>Nuestro acreditado URAC <a href=\"https:\/\/ameripharmaspecialty.com\/es\/\">farmacia especializada<\/a> ofertas <a href=\"https:\/\/ameripharmaspecialty.com\/es\/home-infusion\/\">terapias de infusi\u00f3n domiciliaria<\/a>, medicamentos dif\u00edciles de encontrar y orientaci\u00f3n de expertos en m\u00e1s de 40 estados y territorios de EE. UU.<\/p>\n\n\n\n<p>Si usted o un ser querido est\u00e1 atravesando las complejidades de la hemofilia A, <a href=\"https:\/\/ameripharmaspecialty.com\/es\/contact-us\/\">Cont\u00e1ctanos<\/a> Para una coordinaci\u00f3n integral y soporte 24\/7\/365. \u00a1Comienza hoy mismo!<\/p>","protected":false},"excerpt":{"rendered":"<p>Los pacientes con hemofilia A tienden a sangrar durante m\u00e1s tiempo que las personas sanas, ya que su cuerpo carece de un factor de coagulaci\u00f3n llamado factor VIII (FVIII). Si usted o un ser querido ha estado experimentando sangrados espont\u00e1neos y frecuentes sin causa aparente, le recomendamos considerar el uso de Afstyla despu\u00e9s de consultar con su m\u00e9dico.<\/p>","protected":false},"author":13,"featured_media":27512,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[6],"tags":[17],"class_list":["post-27513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-hemophilia","tag-dr-saba-rassouli"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Afstyla: Factor VIII Therapy for Patients With Hemophilia A<\/title>\n<meta name=\"description\" content=\"Discover Afstyla, the factor VIII therapy for hemophilia A patients. Receive copay assistance &amp; at-home Afstyla treatment from AmeriPharma\u00ae Specialty Pharmacy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Afstyla: Factor VIII Therapy for Patients With Hemophilia A\" \/>\n<meta property=\"og:description\" content=\"Discover Afstyla, the factor VIII therapy for hemophilia A patients. Receive copay assistance &amp; at-home Afstyla treatment from AmeriPharma\u00ae Specialty Pharmacy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-14T17:28:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-17T16:40:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Saba Rassouli, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/\"},\"author\":{\"name\":\"Dr. Saba Rassouli, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\"},\"headline\":\"Afstyla: The First Single-Chain Factor VIII Therapy for Patients With Hemophilia A\",\"datePublished\":\"2025-01-14T17:28:00+00:00\",\"dateModified\":\"2025-06-17T16:40:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/\"},\"wordCount\":1238,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/hemophilia-afstyla.jpg\",\"keywords\":[\"Dr. Saba Rassouli\"],\"articleSection\":[\"Hemophilia\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/\",\"name\":\"Afstyla: Factor VIII Therapy for Patients With Hemophilia A\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/hemophilia-afstyla.jpg\",\"datePublished\":\"2025-01-14T17:28:00+00:00\",\"dateModified\":\"2025-06-17T16:40:35+00:00\",\"description\":\"Discover Afstyla, the factor VIII therapy for hemophilia A patients. Receive copay assistance & at-home Afstyla treatment from AmeriPharma\u00ae Specialty Pharmacy.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/hemophilia-afstyla.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/hemophilia-afstyla.jpg\",\"width\":1280,\"height\":853,\"caption\":\"A gloved hand holding a blood sample tube with a hemophilia positive label\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/hemophilia\\\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Afstyla: The First Single-Chain Factor VIII Therapy for Patients With Hemophilia A\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/vi\\\/#\\\/schema\\\/person\\\/f70b3467e035aab4ae14bdadd64c5c01\",\"name\":\"Dr. Saba Rassouli, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g\",\"caption\":\"Dr. Saba Rassouli, PharmD\"},\"description\":\"Dr. Saba Rassouli, PharmD was born and raised in Iran. She received her pharmacy degree from Marshall B. Ketchum University in 2022, where she graduated cum laude. The most rewarding part of her job is having the opportunity to care for each patient as if they were family and hearing about how happy and satisfied they are with the services provided by AmeriPharma. In her free time, she likes to go on walks, read books, and try different restaurants and foods.\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/es\\\/author\\\/saba-rassouli\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Afstyla: Terapia con factor VIII para pacientes con hemofilia A","description":"Descubra Afstyla, la terapia de factor VIII para pacientes con hemofilia A. Reciba asistencia con el copago y tratamiento domiciliario con Afstyla en la Farmacia Especializada AmeriPharma\u00ae.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/","og_locale":"es_MX","og_type":"article","og_title":"Afstyla: Factor VIII Therapy for Patients With Hemophilia A","og_description":"Discover Afstyla, the factor VIII therapy for hemophilia A patients. Receive copay assistance & at-home Afstyla treatment from AmeriPharma\u00ae Specialty Pharmacy.","og_url":"https:\/\/ameripharmaspecialty.com\/es\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2025-01-14T17:28:00+00:00","article_modified_time":"2025-06-17T16:40:35+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg","type":"image\/jpeg"}],"author":"Dr. Saba Rassouli, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Saba Rassouli, PharmD","Est. reading time":"6 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/"},"author":{"name":"Dr. Saba Rassouli, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01"},"headline":"Afstyla: The First Single-Chain Factor VIII Therapy for Patients With Hemophilia A","datePublished":"2025-01-14T17:28:00+00:00","dateModified":"2025-06-17T16:40:35+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/"},"wordCount":1238,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg","keywords":["Dr. Saba Rassouli"],"articleSection":["Hemophilia"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/","name":"Afstyla: Terapia con factor VIII para pacientes con hemofilia A","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg","datePublished":"2025-01-14T17:28:00+00:00","dateModified":"2025-06-17T16:40:35+00:00","description":"Descubra Afstyla, la terapia de factor VIII para pacientes con hemofilia A. Reciba asistencia con el copago y tratamiento domiciliario con Afstyla en la Farmacia Especializada AmeriPharma\u00ae.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg","width":1280,"height":853,"caption":"A gloved hand holding a blood sample tube with a hemophilia positive label"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/hemophilia\/afstyla-the-first-single-chain-factor-viii-therapy-for-patients-with-hemophilia-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/vi\/"},{"@type":"ListItem","position":2,"name":"Afstyla: The First Single-Chain Factor VIII Therapy for Patients With Hemophilia A"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#website","url":"https:\/\/ameripharmaspecialty.com\/vi\/","name":"Cuidado especializado AmeriPharma\u00ae","description":"Atenci\u00f3n especializada por AmeriPharma","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/vi\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#organization","name":"Atenci\u00f3n especializada de Ameripharma","url":"https:\/\/ameripharmaspecialty.com\/vi\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/vi\/#\/schema\/person\/f70b3467e035aab4ae14bdadd64c5c01","name":"Dra. Saba Rassouli, Farmac\u00e9utica","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a5087340dca0d3046e3ff88f5dfa11d515d21ea9e06e6aec23e56d7fddfee7ce?s=96&d=mm&r=g","caption":"Dr. Saba Rassouli, PharmD"},"description":"La Dra. Saba Rassouli, doctora en farmacia, naci\u00f3 y creci\u00f3 en Ir\u00e1n. Obtuvo su t\u00edtulo en farmacia en la Universidad Marshall B. Ketchum en 2022, donde se gradu\u00f3 con honores. Lo m\u00e1s gratificante de su trabajo es tener la oportunidad de atender a cada paciente como si fuera de su familia y escuchar lo contentos y satisfechos que est\u00e1n con los servicios de AmeriPharma. En su tiempo libre, le gusta pasear, leer y probar diferentes restaurantes y comidas.","url":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"uagb_comment_info":0,"uagb_excerpt":"Hemophilia A patients tend to bleed longer than healthy individuals since their body lacks a blood clotting factor called factor VIII (FVIII). If you or your loved one has been experiencing spontaneous and frequent bleeds without any obvious cause, you may want to consider using Afstyla after consulting with your doctor.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2025\/06\/hemophilia-afstyla.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Saba Rassouli, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/es\/author\/saba-rassouli\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/es\/category\/hemophilia\/\" rel=\"category tag\">Hemophilia<\/a>","rttpg_excerpt":"Hemophilia A patients tend to bleed longer than healthy individuals since their body lacks a blood clotting factor called factor VIII (FVIII). If you or your loved one has been experiencing spontaneous and frequent bleeds without any obvious cause, you may want to consider using Afstyla after consulting with your doctor.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/comments?post=27513"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/posts\/27513\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media\/27512"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/media?parent=27513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/categories?post=27513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/es\/wp-json\/wp\/v2\/tags?post=27513"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}